Comparison between obese and non-obese nonalcoholic fatty liver disease
Wah-Kheong Chan
Clin Mol Hepatol. 2023;29(Suppl):S58-S67. Published online 2022 Dec 5 DOI: https://doi.org/10.3350/cmh.2022.0350
|
Citations to this article as recorded by
Impact of nonalcoholic fatty liver disease on the risk of gallbladder polyps in lean and non-obese individuals: A cohort study
Nam Hee Kim, Ji Hun Kang, Hong Joo Kim
Hepatobiliary & Pancreatic Diseases International.2024;[Epub] CrossRef Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study
Changhui Yu, Shiming He, Maobin Kuang, Chao Wang, Xin Huang, Guotai Sheng, Yang Zou
BMC Endocrine Disorders.2024;[Epub] CrossRef Triglycerides Mediate the Influence of Body Mass Index on Non-Alcoholic Fatty Liver Disease in a Non-Obese Chinese Population with Normal Low-Density Lipoprotein Cholesterol Levels
Xixi Han, Jingwen Kong, Hemin Zhang, Yuan Zhao, Yafeng Zheng, Chao Wei
Obesity Facts.2024; 17(2): 191. CrossRef Genetic and Metabolic Characteristics of Lean Nonalcoholic Fatty Liver Disease in a Korean Health Examinee Cohort
Huiyul Park, Eileen L. Yoon, Goh Eun Chung, Eun Kyung Choe, Jung Ho Bae, Seung Ho Choi, Mimi Kim, Woochang Hwang, Hye-Lin Kim, Sun Young Yang, Dae Won Jun
Gut and Liver.2024; 18(2): 316. CrossRef Association between nonalcoholic fatty liver disease and gallstone risk in nonobese and lean individuals
Nam Hee Kim, Ji Hun Kang, Hong Joo Kim
European Journal of Gastroenterology & Hepatology.2024;[Epub] CrossRef Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Ho Soo Chun, Minjong Lee
Clinical and Molecular Hepatology.2023; 29(2): 377. CrossRef Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy
Wah-Loong Chan, Shi-En Chong, Felicia Chang, Lee-Lee Lai, Kee-Huat Chuah, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Wah-Kheong Chan
Hepatology International.2023; 17(4): 870. CrossRef Food Network Analysis in Non-Obese Patients with or without Steatosis
Rossella Donghia, Pasqua Letizia Pesole, Sergio Coletta, Caterina Bonfiglio, Giovanni De Pergola, Sara De Nucci, Roberta Rinaldi, Gianluigi Giannelli
Nutrients.2023; 15(12): 2713. CrossRef Response to letter to editor: Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B
Yong‐Wen Leow, Wah‐Kheong Chan
Journal of Viral Hepatitis.2023; 30(8): 712. CrossRef Visceral fat: A key mediator of NAFLD development and progression
Savita Bansal, Meenakshi Vachher, Taruna Arora, Bhupender Kumar, Archana Burman
Human Nutrition & Metabolism.2023; 33: 200210. CrossRef Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance
Madalina Andreea Robea, Ioana-Miruna Balmus, Irina Girleanu, Laura Huiban, Cristina Muzica, Alin Ciobica, Carol Stanciu, Carmen Diana Cimpoesu, Anca Trifan
Medicina.2023; 59(9): 1614. CrossRef Zebrafish as a Useful Model System for Human Liver Disease
Nobuyuki Shimizu, Hiroshi Shiraishi, Toshikatsu Hanada
Cells.2023; 12(18): 2246. CrossRef Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
Eugene Han, Yong-ho Lee
Clinical and Molecular Hepatology.2023; 29(4): 980. CrossRef Associations of Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease With Cardiovascular Healthy Outcomes
Wentao Wu, Wen Ma, Shiqi Yuan, Aozi Feng, Li Li, Haoxiao Zheng, Shuna Li, Ningxia He, Yuli Huang, Jun Lyu
Journal of the American Heart Association.2023;[Epub] CrossRef
|